X

X T L Biopharmaceuticals Ltd
TASE:XTLB

Watchlist Manager
X T L Biopharmaceuticals Ltd
TASE:XTLB
Watchlist
Price: 2.4 ILS 4.35%
Market Cap: 21.2m ILS

Net Margin
X T L Biopharmaceuticals Ltd

0%
Current
0%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
3.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

X T L Biopharmaceuticals Ltd
Glance View

Market Cap
21.2m ILS
Industry
Biotechnology

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The firm pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

XTLB Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
3.1m
/
Revenue
0
What is the Net Margin of X T L Biopharmaceuticals Ltd?

Based on X T L Biopharmaceuticals Ltd's most recent financial statements, the company has Net Margin of 0%.

Back to Top